These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21629190)

  • 1. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis.
    Pineda Mde L; Thompson SF; Summers K; de Leon F; Pope J; Reid G
    Med Sci Monit; 2011 Jun; 17(6):CR347-54. PubMed ID: 21629190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial.
    Mandel DR; Eichas K; Holmes J
    BMC Complement Altern Med; 2010 Jan; 10():1. PubMed ID: 20067641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial.
    Alipour B; Homayouni-Rad A; Vaghef-Mehrabany E; Sharif SK; Vaghef-Mehrabany L; Asghari-Jafarabadi M; Nakhjavani MR; Mohtadi-Nia J
    Int J Rheum Dis; 2014 Jun; 17(5):519-27. PubMed ID: 24673738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study.
    Hatakka K; Martio J; Korpela M; Herranen M; Poussa T; Laasanen T; Saxelin M; Vapaatalo H; Moilanen E; Korpela R
    Scand J Rheumatol; 2003; 32(4):211-5. PubMed ID: 14626627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
    Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
    Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study.
    Al-Gareeb AIA; Gorial FI; Mahmood AS
    Clin Rheumatol; 2018 Oct; 37(10):2633-2641. PubMed ID: 29882203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis.
    Vaghef-Mehrabany E; Alipour B; Homayouni-Rad A; Sharif SK; Asghari-Jafarabadi M; Zavvari S
    Nutrition; 2014 Apr; 30(4):430-5. PubMed ID: 24355439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
    Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK
    Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial.
    Abdallah MS; Alarfaj SJ; Saif DS; El-Naggar ME; Elsokary MA; Elsawah HK; Abdelsattar Zaki S; Wahsh EA; Abo Mansour HE; Mosalam EM
    Int Immunopharmacol; 2021 Jun; 95():107575. PubMed ID: 33773207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
    Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
    Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.
    Genovese MC; Kavanaugh A; Weinblatt ME; Peterfy C; DiCarlo J; White ML; O'Brien M; Grossbard EB; Magilavy DB
    Arthritis Rheum; 2011 Feb; 63(2):337-45. PubMed ID: 21279990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
    Kremer JM; Genovese MC; Cannon GW; Caldwell JR; Cush JJ; Furst DE; Luggen ME; Keystone E; Weisman MH; Bensen WM; Kaine JL; Ruderman EM; Coleman P; Curtis DL; Kopp EJ; Kantor SM; Waltuck J; Lindsley HB; Markenson JA; Strand V; Crawford B; Fernando I; Simpson K; Bathon JM
    Ann Intern Med; 2002 Nov; 137(9):726-33. PubMed ID: 12416946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial.
    Lee S; Cho Y; Kim J; Kang JW; Yoon GY; Lee JH; Jung SY; Kwon O; Shin KM; Lee JD
    Trials; 2018 Sep; 19(1):471. PubMed ID: 30176923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
    Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S;
    J Rheumatol; 2002 Aug; 29(8):1623-30. PubMed ID: 12180720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of probiotic supplementation in rheumatoid arthritis: a meta-analysis of randomized, controlled trials.
    Aqaeinezhad Rudbane SM; Rahmdel S; Abdollahzadeh SM; Zare M; Bazrafshan A; Mazloomi SM
    Inflammopharmacology; 2018 Feb; 26(1):67-76. PubMed ID: 29302905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.